Early Evolution and Correlates of Urine Albumin Excretion in Patients Presenting With Acutely Decompensated Heart Failure

被引:33
|
作者
Koyama, Satoshi [1 ]
Sato, Yukihito [1 ]
Tanada, Yohei [1 ]
Fujiwara, Hisayoshi [1 ]
Takatsu, Yoshiki [1 ]
机构
[1] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiovasc Med, Amagasaki, Hyogo 6600828, Japan
关键词
biomarker; cardiorenal syndrome; heart failure; microalbuminuria heart failure; natriuretic peptide; proteinuria; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; ANGIOTENSIN-II; RENAL-FUNCTION; MICROALBUMINURIA; MORTALITY; RISK; PROTEINURIA; PREVALENCE; TRIAL;
D O I
10.1161/CIRCHEARTFAILURE.112.000152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Urine albumin excretion is an important predictor of adverse cardiovascular events in various populations. Its correlation in patients with acute heart failure has not been described. Methods and Results-This prospective, observational study included 115 patients presenting with acute heart failure. The urine albumin/creatinine ratio (UACR) was measured from spot urine samples collected on days 1 and 7 of hospitalization. Median UACR decreased from 83 to 22 mg/gCr on days 1 and 7, respectively (P<0.0001). The proportion of patients with normoalbuminuria (UACR <30 mg/gCr) increased from 31% on day 1 to 60% on day 7, whereas the proportion with microalbuminuria (UACR between 30 and 299 mg/gCr) and macroalbuminuria (UACR >= 300 mg/gCr) decreased, respectively, from 42% and 27% on day 1 to 30% and 10% on day 7 (P<0.0001). These changes in UACR were correlated with changes in serum bilirubin and N-terminal pro b-type natriuretic peptide concentrations (correlation coefficients 1.087 and 0.384, respectively; 95% confidence interval, 0.394-1.781 and 0.087-0.680, respectively; and P=0.003 and 0.013, respectively), although they were not correlated with change in estimated glomerular filtration rate. Conclusions-In this sample of patients presenting with acute heart failure, urine albumin excretion was often increased at admission to the hospital and decreased significantly within 7 days of treatment. The decrease was correlated with serum N-terminal pro b-type natriuretic peptide and bilirubin concentrations, although neither with baseline nor with changes in indices of renal function.
引用
收藏
页码:227 / +
页数:9
相关论文
共 50 条
  • [31] De Novo Acute Heart Failure and Acutely Decompensated Chronic Heart Failure
    Hummel, Astrid
    Empen, Klaus
    Doerr, Marcus
    Felix, Stephan B.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (17): : 298 - 309
  • [32] Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure
    Jason Stencel
    Indranee Rajapreyar
    Rohan Samson
    Thierry Le Jemtel
    Current Heart Failure Reports, 2022, 19 : 364 - 374
  • [33] De Novo Acute Heart Failure and Acutely Decompensated Chronic Heart Failure
    Spiliopoulos, Sotirios
    Koerfer, Reiner
    Tenderich, Gero
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (03): : 39 - 39
  • [34] Colchicine in acutely decompensated heart failure: the COLICA trial
    Pascual-Figal, Domingo
    Nunez, Julio
    Perez-Martinez, Maria T.
    Gonzalez-Juanatey, Jose Ramon
    Taibo-Urquia, Mikel
    Llacer-Iborra, Pau
    Delgado, Juan
    Villar, Sandra
    Mirabet, Sonia
    Aimo, Alberto
    Riquelme-Perez, Alejandro
    Anguita-Sanchez, Manuel
    Martinez-Selles, Manuel
    Noguera-Velasco, Jose A.
    Ibanez, Borja
    Bayes-Genis, Antoni
    EUROPEAN HEART JOURNAL, 2024,
  • [35] Use of carperitide infusion for acutely decompensated heart failure
    Yoshihisa Morita
    Shun Kohsaka
    Kazuki Oshima
    Tsutomu Yoshikawa
    Keiichi Fukuda
    Critical Care, 16
  • [36] Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure
    Stencel, Jason
    Rajapreyar, Indranee
    Samson, Rohan
    Le Jemtel, Thierry
    CURRENT HEART FAILURE REPORTS, 2022, 19 (05) : 364 - 374
  • [37] Possible Role of Increased Urine Albumin Excretion on Admission Due to Acute Decompensated Heart Failure as a Predictive Marker of Re-Hospitalization
    Matsumoto, Yuki
    Asakura, Masanori
    Orihara, Yoshiyuki
    Okuhara, Yoshitaka
    Kashiwase, Kazunori
    Ishihara, Masaharu
    CIRCULATION, 2019, 140
  • [38] Use of carperitide infusion for acutely decompensated heart failure
    Morita, Yoshihisa
    Kohsaka, Shun
    Oshima, Kazuki
    Yoshikawa, Tsutomu
    Fukuda, Keiichi
    CRITICAL CARE, 2012, 16 (01):
  • [39] Comparison of serial monitoring of multiple biomarkers in patients with acutely decompensated heart failure
    Zhang, R. Rongcheng
    Zhang, Y.
    An, T.
    Huang, Y.
    Zhou, Q.
    Zhang, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 216 - 217
  • [40] Levosimendan therapy in patients with acutely decompensated heart failure Outcomes and mortality predictors
    Briosa, A.
    Alegria, S.
    Marques, A.
    Pereira, A. R.
    Sebaiti, D.
    Santos, J.
    Gomes, A. C.
    Simoes, O.
    Almeida, A. R.
    Miranda, R.
    Pereira, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 167 - 167